Genomics

Dataset Information

0

AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer [ChIP-seq]


ABSTRACT: Castration resistant prostate cancer (CRPC) remains an incurable disease stage with ineffective treatments options. Here, the androgen receptor (AR) coactivators CBP/p300, which are histone acetyltransferases, were identified as critical mediators of DNA damage repair (DDR) to potentially enhance therapeutic targeting of CRPC. Key findings demonstrate that CBP/p300 expression increases with disease progression and selects for poor prognosis in metastatic disease. CBP/p300 bromodomain inhibition enhances response to standard of care therapeutics. Functional studies, CBP/p300 cistrome mapping, and transcriptome in CRPC revealed that CBP/p300 regulates DDR. Further mechanistic investigation showed that CBP/p300 attenuation via therapeutic targeting and genomic knockdown decreases homologous recombination (HR) factors in vitro, in vivo, and in human prostate cancer (PCa) tumors ex vivo. Similarly, CBP/p300 expression in human prostate tissue correlates with HR factors. Lastly, targeting CBP/p300 impacts HR-mediate repair and patient outcome. Collectively, these studies identify CBP/p300 as drivers of PCa tumorigenesis and lay the groundwork to optimize therapeutic strategies for advanced PCa via CBP/p300 inhibition, potentially in combination with AR-directed and DDR therapies.

ORGANISM(S): Homo sapiens

PROVIDER: GSE275777 | GEO | 2024/09/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-09-04 | GSE275778 | GEO
2020-12-03 | GSE162564 | GEO
2022-10-13 | PXD029520 | Pride
2022-10-14 | PXD029454 | Pride
2015-04-03 | E-GEOD-67537 | biostudies-arrayexpress
2016-03-08 | E-GEOD-72714 | biostudies-arrayexpress
2016-03-08 | E-GEOD-72483 | biostudies-arrayexpress
2016-03-08 | GSE72714 | GEO
2016-03-08 | GSE72483 | GEO
2015-04-03 | GSE67537 | GEO